As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.
17 Analysts have issued a Shionogi & forecast:
17 Analysts have issued a Shionogi & forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | 437,263 437,263 |
4%
4%
|
|
| Gross Profit | 374,317 374,317 |
4%
4%
|
|
| EBITDA | 158,488 158,488 |
17%
17%
|
|
| EBIT (Operating Income) EBIT | 155,505 155,505 |
19%
19%
|
|
| Net Profit | 170,844 170,844 |
11%
11%
|
|
In millions JPY.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan.
| Head office | Japan |
| CEO | Isao Teshirogi |
| Employees | 4,959 |
| Founded | 1878 |
| Website | www.shionogi.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


